Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin versus rosuvastatin in adults with type 2 diabetes
IRCT20250320065133N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of atorvastatin and rosuvastatin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: furin, insulin and 7 more. Started Apr 2025; status: completed.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20250320065133N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250320065133N1.